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CYCLOSPORINE (CsA) has proven to be 
an effective immunosuppressant. There 
is wide variability in the pharmacokinetics of 
CsA in transplant patients.' Variability in the 
elimination of CsA appears to be a major 
contributing factor for such an observation. 
CsA is eliminated primarily by hepatic 
metabolism, which involves N-demethylation 
and hydroxylation of various amino acid resi-
dues.2 Carboxylation of the novel amino acid 1 
has also been reported in humans and rabbits.3 
Less than 1 % of the administered dose is 
excreted as unchanged CsA in the bile and the 
urine obtained from dogs or transplant 
patients.· 
Animal models are commonly used in 
transplant research. However, the pharmaco-
kinetics of CsA are not completely character-
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izcd in all the animal species. Available infor-
mation indicates large variation in absorption, 
plasma protein binding, and elimination· or 
CsA between several animals. s-7 However •. 
very little is known about the metabolic fate of 
CsA in various animals. The objective of tJU. 
study is to investigate the metabolic profile oft 
CsA in rats, rabbits, dogs, and cats as it 
relates to CsA metabolism in transplant 
patients. 
METHODS 
The animals studied include four male beagle dop 
(body weight of 15 q) with cholcdochouretel'OltOmy, 
four male AC Lewis rats each weilhing about 250 g. four 
male random soun:e domestic short hair cats each wei",-
ing about 1.9 q, and two male New Zealand rabbits. 
weighing 3 ka each. The animals received CsA (SandiJD. 
mune, Sandoz Inc. Basel. Switzerland) diluted in noriDal 
saline intravenously (IV) (3 to 5 mg/q) over two miJt. 
utes. Blood samples were obtained from the femoral veiD 
(dogs and cats), tail vein (rats), or marginal ear veia 
(rabbits) at times corresponding to approximately one to 
two half-lives after CIA administration from each group 
of animals (Table 1). Blood was stored in heparinized 
glass tubes at SOC and extracted within 1 week. Cumula-
tive urine wu also collected over a time period c0rre-
sponding to four half-lives of CsA in rats, cats. aDd 
rabbits. In dogs combined urine and bile were collected 
for 12 hours. 
For comparative PUrpoleS, 12-hour trough blood sam-
ples were obtained from four liver transplant petiOllIS 
receiving IV CIA in doses ranging from 100 to 240 JIll. 
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Bile wascollootod from tho T tube in throe additional 
patients. CwnuJatiYo uri ... sam ... wen alao collected 
over 24 boun fromrov kidney transplam patients receiy.. 
ina 1 SO to 2.000 m. of CIA orally. 
CsA and several of ill metabolites wore analyzed in 
blood. urine, and bile by a pacliont elution high-prell~ 
liquid chromatopapbic method cIovelopocl in our labora-
tory.' In brief, this method CDIIIiats of extraction of CIA 
and ill metabolites mto otIIer, sublequat purificatiott 
uain. hexane. and re-oxtracUon iato otIIer. Cydolporioe 
D was IIICICl u the internal standant. The raiduo was 
injected OIIto. Rosolft C·l8 coIlUIUl (Waters, Milrord. 
MA) maintained at 7o-C. SepuatioDof different CsA 
motabolitea M-17, Mol, M-II, M·21 (nomondature u 
per Maurer CIt all) from CsA and other CIlCfoIeDaaa 
com~ was acbicverI· ... amobiJepbuo ofacotoni-
trite and .... ne cmlpoeition of themobilo p8ue was 
chanpd from 4"" acetoaitriIe at time G to 73" acet0ni-
trile at 55 minutes.. Pure IDCItabolites (Mo17, M-18, M·I, 
and M-21) isolated from butnan bi.le were used for 
construction of tho standard curve. 
Analysis of variance wu used to determine the pres-
enco of any lipificant difl'eroncos in the ratio of M-17 to 
CsA, M·21 to CsA, and M-I to CsA in all the species 
studied. 
RESULTS 
The analytic method used in this study 
produced optimal separation of different CsA 
metabolites in blood, urine, and bile. Figure I 
illustrates the chromatogram of the extract of 
blood from a liver transplant patient. a rabbit. 
a rat, a cat, and a dog. The retention times 
were approximately 25 minutes (M-17). 26.3 
minutes (M-l), 27.9 minutes (M-18). 3S min-
utes (M-21) 45.8 minutes (CsA), and 49.7 
minutes (cyclosporine D). The coefficient of 
variation of the method ranged from I.S% for 
M-17 and CsA to 9.3% for M-IS. The mini-
mum detectable concentration of CsA and all 
the metabolites was 20 ng/mL. The standard 
curve was linear over a concentration range of . 
50 to 2.000 ng/mL. 
The mean (± SD) blood concentrations of 
CsA. M-17, M~fK M-tS, and M-21 in liver 
transplant patients. rabbits. rats. cats, and 
dogs are listed in Table 2. In liver transplant 
patients, the concentration of M-17 was 
higher as compared to CsA and the other 
metabolites. In rabbits, even though the con-
centration of CsA was higher than that of any 
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other metabolites, M-17 appeared to be the 
major metabolite. In rats, M-I is the major 
metabolite while similar concentrations of 
M-I, M-21, and M-17 were observed in cats. 
The mean (± SD) ratio of M-17 to CsA 
blood concentration in liver transplant 
patients, rabbits, rats, cats, and dogs were 
2.14 (±0.6), 0.92 (±0.3S), 0.7S (±0.33), 0.2 
(±0.07), and 0.36 (±0.13), respectively (Fig 
2). There was a significant (P < .OS) interspe-
cies difference in the M-17 to CsA ratio. The 
M-I to CIA ratio of O.S2, 0.52, 1.1.0.46, and 
1.0 in liver transplant patients, rabbits, cats, 
rats, and dogs. respectively was not signifi-
cantly different from each other. There was, 
however, a significant (P < .05) difference in 
the M-21 to CsA ratio between liver trans-
plant patients (0.14), rabbits (0.4), rats 
(0.048), cats (0.96), and dogs (0.63). 
In all the animals tested less than 1 % of the 
CsA dose was excreted in the urine as the 
parent drug. Significantly (P < .OS) different 
amounts of CsA and its metabolites were 
excreted in the urine of rats and in the urine 
and bile mixture obtained from dogs (Table 
3). In rats most of the CsA derived material 
excreted in the urine was M-I (3% of the 
dose) and M-17 (1.2%). In the dog bile and 
urine mixture, M-I and M-21 were the major 
metabolites. Large amounts of M-17 and 
M-lS were also present in the bile, urine mix-
ture. Cats primarily excreted M-l and M-21 
while rabbit's urine contained M-I, M-lS, 
and M-l7.In human bile, the major metabo-
lite is M-17. The concentrations of M-17 and 
M-l were higher than M-21, M-lS, and CsA 
in the bile. 
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DISCUSSION 
Even though CsA has a unique and com-
plex chemical structure ita metabolie path-
ways involve simple hydroxylation or 
N-demethylation at various amino acid resi-
dues or carboxylation of the. methyl group in 
, amino acid I. M-17 andDM~lare the primary 
hydroxy metabolites of CsA while M-21 is the 
primary N-demethylated CsA. A number of 
secondary metabolites have been identified in 
buman urine and bile or urine from animals 
dosed with CsA. M-18 is a secondary metabo-
lite of CsA and is a cyclic ether analog of 
M-17. A carboxy metabolite of CsA is 
believed to be the major CsA metabolite in 
human and rabbit bile. In the present study 
due to lack of pure standards this metabolite 
was not quantitated. 
M-I' has been shown to possess significant 
in vitro immunosuppressive activity against 
biopsy-grown lymphocytes.' M-I, M-18, and 
M·21 are much less active in in vitro tests.' In 
.' 
.. ';:;. .... 
, oK~ '\ K~ • 
kidney," heart," liver" and boDe marrow' 
transplant patients M-I' trough concentra-
tions are often higber than trough CIA con. 
centrations and may contribute to the overall 
immullOlUppressive activity. 
The· present study indicates that while 
M·17 is the major metaboliteofCsA in'liver 
transplant patients and rabbits,. M-I appean 
to be the major metabolite in rata and dogs 
and M-21, M-I, and M-I' are in siniilar 
concentrations in cats. Recently. Waper et 
aliZ have reported M-l to be the major CsA 
metabolite in rat blood and urine. While the 
metabolic pathways of CsA are similar in all 
the animals tested the relative importance of 
the various pathways differ between different 
species. In view of the fact that M-17 is the 
only CsA metabolite with significant in vitro 
immunosuppressive activity, careful attention 
should be paid to the selection of animal 
models for pharmacokinetic and pharmacody· 
namic studies involving CsA. 
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